A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone.

A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone. Circulation. 2021 10 19; 144(16):1269-1271.

View in: PubMed